Cell-derived microparticles unveil their fibrinolytic and proteolytic function

Médecine sciences : M/S
Loïc Doeuvre, Eduardo Anglés-Cano


Cell-derived microparticles (MP) are membrane microvesicles, 0.1-1 microm in size, shed by cells following activation or during apoptosis in a variety of pathological conditions. MPs released by blood cells or by vascular endothelial cells display molecular signatures that allow their identification and functional characterization. In addition, they provide tissue factor (TF) and a procoagulant phospholipid surface. Therefore, at present, the most strongly established applied research on MPs is their procoagulant activity as a determinant of thrombotic risk in various clinical conditions. Previous studies have indicated that MPs derived from malignant cells express matrix metalloproteinases, urokinase and its receptor (uPA/uPAR) that, in the presence of plasminogen, may act in concert to degrade extracellular matrix proteins. Recently, it was shown that MPs from TNFa-stimulated endothelial cells served as a surface for interaction with plasminogen and its conversion into plasmin by the uPA/uPAR system expressed at their surface. This capacity of MPs to promote plasmin generation confers them a new profibrinolytic and proteolytic function that may be of relevance in fibrinolysis, cell migration, angiogenesis, dissemination of ma...Continue Reading


May 1, 1967·British Journal of Haematology·P Wolf
Jul 4, 1997·The Journal of Biological Chemistry·Angela GinestraMaria Letizia Vittorelli
Sep 2, 1998·Toxicon : Official Journal of the International Society on Toxinology·D MebsH W Herrmann
Nov 13, 1998·Biologicals : Journal of the International Association of Biological Standardization·G Siegl, P Cassinotti
Jul 7, 1999·The Journal of Clinical Investigation·V CombesFrançoise Dignat-George
Jul 23, 1999·Annals of the New York Academy of Sciences·V DoloMaria Letizia Vittorelli
Jul 20, 2001·Annals of the New York Academy of Sciences·H R Lijnen
Sep 19, 2003·Molecular Biotechnology·Vikki M AbrahamsGil Mor
Oct 3, 2003·The Journal of Biological Chemistry·Simona TavernaMaria Letizia Vittorelli
Nov 25, 2003·Journal of Thrombosis and Haemostasis : JTH·M N Abid HusseinA Sturk
Feb 11, 2004·Médecine sciences : M/S·S RiveraM Khrestchatisky
Mar 5, 2004·Médecine sciences : M/S·Maria Carmen MartínezJean-Marie Freyssinet
Jun 11, 2004·Médecine sciences : M/S·Giovanna Chimini
Jun 18, 2004·European Journal of Clinical Investigation·M DiamantR Nieuwland
Jul 17, 2004·Current Opinion in Hematology·Olivier MorelJean-Marie Freyssinet
Oct 1, 2004·Journal of Thrombosis and Haemostasis : JTH·Wenche JyR P Hebbel
Oct 7, 2004·Cancer Research·Laura E GravesDavid A Fishman
Oct 23, 2004·International Journal of Cancer. Journal International Du Cancer·Anna Janowska-WieczorekMariusz Z Ratajczak
Feb 11, 2005·Proceedings of the National Academy of Sciences of the United States of America·Jörg H W DistlerOliver Distler
Apr 2, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Arturo Garcia-TouchardRobert S Schwartz
Apr 21, 2005·Thrombosis and Haemostasis·K DanøJohn Rømer
Jun 7, 2005·La Revue de médecine interne·Olivier MorelFlorence Toti
Jul 15, 2005·Advances in Clinical Chemistry·Joaquin J JimenezYeon S Ahn
Feb 8, 2006·Journal of Thrombosis and Haemostasis : JTH·P RossignolH R Lijnen
Jul 25, 2006·Behavioural Brain Research·F A ChaillanF S Roman
Sep 23, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Olivier MorelJean-Marie Freyssinet
Jan 24, 2007·Journal of Thrombosis and Haemostasis : JTH·I Del CondeJ A López
Feb 24, 2007·Nature Reviews. Molecular Cell Biology·Andrea Page-McCawZena Werb
Mar 3, 2007·Cancer Research·Marcin WysoczynskiMariusz Z Ratajczak
Mar 16, 2007·British Journal of Haematology·Susan F Lynch, Christopher A Ludlam
Apr 27, 2007·Neoplasia : an International Journal for Oncology Research·Danilo MillimaggiV Dolo
May 29, 2007·International Review of Neurobiology·Lawrence L HorstmanYeon S Ahn
Jan 5, 2008·Seminars in Thrombosis and Hemostasis·Anoop K EnjetiMichael Seldon
May 10, 2008·Médecine sciences : M/S·Lionel Blanc, Michel Vidal
Jul 23, 2008·Perspectives in Vascular Surgery and Endovascular Therapy·Kimon Bekelis, Nicos Labropoulos
Aug 20, 2009·Acta Crystallographica. Section D, Biological Crystallography·Kenji OkuyamaLuigi Vitagliano


Feb 6, 2010·Médecine sciences : M/S·Fanny AngelotFrancine Garnache-Ottou
May 22, 2009·Journal of Neurochemistry·Loïc DoeuvreEduardo Anglés-Cano
Dec 29, 2009·Médecine sciences : M/S·Gérard SociéRégis Peffault de Latour
Oct 24, 2009·Médecine sciences : M/S·Eduardo Anglés-CanoSTROKAVENIR

Related Concepts

Blood Coagulation
Plasma Membrane
Ovarian Neoplasm
Chinese Hamster Ovary Cell
Apoptosis, Intrinsic Pathway

Related Feeds


Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

© 2021 Meta ULC. All rights reserved